164 related articles for article (PubMed ID: 2183888)
21. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies.
Ogawa S; Hangaishi A; Miyawaki S; Hirosawa S; Miura Y; Takeyama K; Kamada N; Ohtake S; Uike N; Shimazaki C
Blood; 1995 Aug; 86(4):1548-56. PubMed ID: 7632963
[TBL] [Abstract][Full Text] [Related]
22. High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21.
Preudhomme C; Warot-Loze D; Roumier C; Grardel-Duflos N; Garand R; Lai JL; Dastugue N; Macintyre E; Denis C; Bauters F; Kerckaert JP; Cosson A; Fenaux P
Blood; 2000 Oct; 96(8):2862-9. PubMed ID: 11023523
[TBL] [Abstract][Full Text] [Related]
23. RAS gene mutations in childhood acute myeloid leukemia: a Pediatric Oncology Group study.
Vogelstein B; Civin CI; Preisinger AC; Krischer JP; Steuber P; Ravindranath Y; Weinstein H; Elfferich P; Bos J
Genes Chromosomes Cancer; 1990 Jul; 2(2):159-62. PubMed ID: 2278970
[TBL] [Abstract][Full Text] [Related]
24. Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.
Farr CJ; Saiki RK; Erlich HA; McCormick F; Marshall CJ
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1629-33. PubMed ID: 3278322
[TBL] [Abstract][Full Text] [Related]
25. Analysis of N-RAS exon-1 mutations in myelodysplastic syndromes by polymerase chain reaction and direct sequencing.
Bar-Eli M; Ahuja H; Gonzalez-Cadavid N; Foti A; Cline MJ
Blood; 1989 Jan; 73(1):281-3. PubMed ID: 2642713
[TBL] [Abstract][Full Text] [Related]
26. RAS gene activation in acute myelogenous leukemia: analysis by in vitro amplification and DNA base sequence determination.
Mane SM; Meltzer SJ; Gutheil JC; Kapil V; Lee EJ; Needleman SW
Genes Chromosomes Cancer; 1990 May; 2(1):71-7. PubMed ID: 2278967
[TBL] [Abstract][Full Text] [Related]
27. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes.
Lyons J; Janssen JW; Bartram C; Layton M; Mufti GJ
Blood; 1988 Jun; 71(6):1707-12. PubMed ID: 3285909
[TBL] [Abstract][Full Text] [Related]
28. [Oncogenes in human leukemia].
Takaku F
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):617-23. PubMed ID: 2650633
[TBL] [Abstract][Full Text] [Related]
29. Glycine-cysteine substitution at codon 13 of the N-ras proto-oncogene in a human T cell non-Hodgkin's lymphoma.
Wodnar-Filipowicz A; Senn HP; Jiricny J; Signer E; Moroni C
Oncogene; 1987; 1(4):457-61. PubMed ID: 3330790
[TBL] [Abstract][Full Text] [Related]
30. Mutations of N-ras oncogene in myelodysplastic syndromes and leukemias detected by polymerase chain reaction.
Mano H; Ishikawa F; Hirai H; Takaku F
Jpn J Cancer Res; 1989 Feb; 80(2):102-6. PubMed ID: 2498243
[TBL] [Abstract][Full Text] [Related]
31. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
Goodrow T; Reynolds S; Maronpot R; Anderson M
Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
[TBL] [Abstract][Full Text] [Related]
32. Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukemia.
Garicochea B; Giorgi R; Odone VF; Dorlhiac-Llacer PE; Bendit I
Leuk Res; 1998 Nov; 22(11):1003-7. PubMed ID: 9783802
[TBL] [Abstract][Full Text] [Related]
33. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.
Radich JP; Kopecky KJ; Willman CL; Weick J; Head D; Appelbaum F; Collins SJ
Blood; 1990 Aug; 76(4):801-7. PubMed ID: 2200539
[TBL] [Abstract][Full Text] [Related]
34. RAS and FMS mutations following cytotoxic therapy for childhood acute lymphoblastic leukaemia.
Taylor C; McGlynn H; Carter G; Baker AH; Warren N; Ridge SA; Owen G; Thompson E; Thompson PW; Jacobs A
Leukemia; 1995 Mar; 9(3):466-70. PubMed ID: 7885045
[TBL] [Abstract][Full Text] [Related]
35. Mutation analysis of the N-ras proto-oncogene in active and remission phase of human acute leukemias.
Senn HP; Trân-Thang C; Wodnar-Filipowicz A; Jiricny J; Fopp M; Gratwohl A; Signer E; Weber W; Moroni C
Int J Cancer; 1988 Jan; 41(1):59-64. PubMed ID: 3275590
[TBL] [Abstract][Full Text] [Related]
36. N-RAS mutations in T-cell acute lymphocytic leukaemia: analysis by direct sequencing detects a novel mutation.
Bar-Eli M; Ahuja H; Foti A; Cline MJ
Br J Haematol; 1989 May; 72(1):36-9. PubMed ID: 2660900
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of the ras gene in myelocytic leukemia by polymerase chain reaction and oligonucleotide probes.
Liu TC; Lin SF; Chen TP; Liu HW; Chang JG
J Formos Med Assoc; 1991 Sep; 90(9):825-30. PubMed ID: 1683380
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the role of the ras protooncogene point mutation in human uveal melanomas.
Soparker CN; O'Brien JM; Albert DM
Invest Ophthalmol Vis Sci; 1993 Jun; 34(7):2203-9. PubMed ID: 8505202
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the N-ras gene in juvenile chronic myelogenous leukemia.
Miyauchi J; Asada M; Sasaki M; Tsunematsu Y; Kojima S; Mizutani S
Blood; 1994 Apr; 83(8):2248-54. PubMed ID: 8161790
[TBL] [Abstract][Full Text] [Related]
40. Multiplex polymerase chain reaction amplification and direct sequencing of homologous sequences: point mutation analysis of the ras genes.
Manam S; Nichols WW
Anal Biochem; 1991 Nov; 199(1):106-11. PubMed ID: 1807152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
